What BIODELIVERY SCIENCES INTERNATIONAL INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bailey Jeffrey Allen | Chief Executive Officer | Mar 22 | Other Transaction · J | −105,133 | — | — | 0 |
| Davis Todd C | Director | Mar 22 | Other Transaction · J | −252,207 | — | — | 0 |
| Greenleaf Peter | Director | Mar 22 | Other Transaction · J | −105,034 | — | — | 0 |
| Watson W. Mark | Director | Mar 22 | Other Transaction · J | −90,663 | — | — | 0 |
| Plesha Scott M. | See Remarks | Mar 22 | Other Transaction · J | −345,127 | — | — | 0 |
| Kotler Kevin | Director | Mar 22 | Other Transaction · J | −7,588,395 | — | — | 0 |
| Smith Thomas B | Chief Medical Officer | Mar 22 | Other Transaction · J | −52,530 | — | — | 0 |
| Sirgo Mark A | Director | Mar 22 | Other Transaction · J | −1,166,866 | — | — | 0 |
| Singh Vanila | Director | Mar 22 | Other Transaction · J | −35,851 | — | — | 0 |
| Bailey Jeffrey Allen | Chief Executive Officer | Mar 09 | Exercise / conversion · M | +5,333 | — | — | 105,133 |
| Kotler Kevin | Director | Feb 11 | Derivative Conversion · C | +2,422,222 | $1.80 | +$4.36M | 7,588,395 |
| Vollins James | See Remarks | Feb 04 | Withheld — tax / exercise cost · F | −9,872 | $3.66 | −$36.1K | 0 |
| Vollins James | See Remarks | Feb 04 | Disclosed 10b5-1 sale · S | −18,541 | $3.60 | −$66.7K | 9,872 |
| Smith Thomas B | Chief Medical Officer | Jan 31 | Exercise / conversion · M | +7,667 | — | — | 52,530 |
| Smith Thomas B | Chief Medical Officer | Jan 31 | Exercise / conversion · M | +7,548 | — | — | 44,863 |
| Vollins James | See Remarks | Jan 31 | Exercise / conversion · M | +3,834 | — | — | 28,413 |
| Vollins James | See Remarks | Jan 31 | Exercise / conversion · M | +8,303 | — | — | 24,579 |
| Plesha Scott M. | See Remarks | Jan 31 | Exercise / conversion · M | +13,334 | — | — | 345,127 |
| Plesha Scott M. | See Remarks | Jan 31 | Exercise / conversion · M | +10,869 | — | — | 331,793 |
| Greenleaf Peter | Director | Jan 27 | Exercise / conversion · M | +10,246 | — | — | 105,034 |
Loading...